• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的早期乳腺癌患者心血管死亡率研究。

A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.

机构信息

Department of Medicine, University of Toronto, Toronto, Ontario, Canada2Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada4Division of Cardiology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.

Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada3Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

出版信息

JAMA Cardiol. 2017 Jan 1;2(1):88-93. doi: 10.1001/jamacardio.2016.3841.

DOI:10.1001/jamacardio.2016.3841
PMID:27732702
Abstract

IMPORTANCE

There is increasing interest in the effect of cardiovascular disease on cancer survivors. However, there are limited contemporary population-based data on the risk of cardiovascular death after early-stage breast cancer.

OBJECTIVE

To describe the incidence of cardiovascular death in a contemporary population of women with early-stage breast cancer while accounting for competing risks.

DESIGN, SETTING, AND PARTICIPANTS: A population-based cohort study was conducted among 98 999 women diagnosed with early-stage breast cancer between April 1, 1998, and March 31, 2012. Patients were followed up until death or were censored on December 31, 2013. Baseline characteristics were determined from administrative databases and the Ontario Cancer registry. Vital statistics data were used to determine the cause of death. Cumulative incidence functions were used to estimate the incidence of cause-specific mortality. We studied the association between baseline characteristics and rates of cardiovascular death using cause-specific hazard functions. The analyses accounted for competing risks of noncardiovascular death. Statistical analysis was performed from July 16, 2015, to August 4, 2016.

EXPOSURES

Early-stage breast cancer, age, cardiovascular disease, hypertension, and diabetes.

MAIN OUTCOMES AND MEASURES

Cause of death, which was classified as breast cancer, cardiovascular disease, other cancers, or other noncancer causes.

RESULTS

Of the 98 999 women (median age, 60 years [interquartile range, 50-71 years]) in the study, 21 123 (21.3%) died during follow-up. The median time to death was 4.2 years (IQR, 2.2-7.1 years). Breast cancer was the most common cause of death (10 550 deaths [49.9%]); 3444 deaths [16.3%] were from cardiovascular causes. Cardiovascular death was infrequent in women younger than 66 years without prior cardiovascular disease, diabetes, or hypertension. Among women 66 years or older, the risks of breast cancer death and cardiovascular death at 10 years were 11.9% (95% CI, 11.6%-12.3%) and 7.6% (95% CI, 7.3%-7.9%), respectively. Among patients with prior cardiovascular disease, the risk of death from breast cancer and cardiovascular disease were equivalent for the first 5 years, after which death from cardiovascular causes was more frequent (10-year cumulative incidence, 14.6% [95% CI, 13.7%-15.4%] for breast cancer vs 16.9% [95% CI, 16.0%-17.8%] for cardiovascular disease). For women 66 years or older who survived 5 years or more after diagnosis of breast cancer, cardiovascular disease exceeded breast cancer as the leading cause of death at 10 years after diagnosis, when the cumulative incidence of each was 5%.

CONCLUSIONS AND RELEVANCE

Cardiovascular death is an important competing risk for older women with early-stage breast cancer. This finding mandates adequate attention to cardiovascular preventive therapy after diagnosis of breast cancer.

摘要

重要性

心血管疾病对癌症幸存者的影响越来越受到关注。然而,目前关于早期乳腺癌患者心血管死亡风险的当代人群数据有限。

目的

描述在考虑竞争风险的情况下,早期乳腺癌女性中心血管死亡的发生率。

设计、地点和参与者:这是一项基于人群的队列研究,纳入了 98999 名于 1998 年 4 月 1 日至 2012 年 3 月 31 日期间被诊断为早期乳腺癌的女性。患者被随访至死亡或于 2013 年 12 月 31 日被删失。基线特征来自于行政数据库和安大略癌症登记处。使用生命统计数据确定死因。累积发病率函数用于估计特定原因死亡率。我们使用特定原因危害函数研究了基线特征与心血管死亡率之间的关系。分析考虑了非心血管死亡的竞争风险。统计分析于 2015 年 7 月 16 日至 2016 年 8 月 4 日进行。

暴露

早期乳腺癌、年龄、心血管疾病、高血压和糖尿病。

主要结局和测量指标

死因,分为乳腺癌、心血管疾病、其他癌症或其他非癌症原因。

结果

在这项研究中的 98999 名女性(中位年龄 60 岁[四分位距,50-71 岁])中,21123 名(21.3%)在随访期间死亡。中位死亡时间为 4.2 年(IQR,2.2-7.1 年)。乳腺癌是最常见的死因(10550 例死亡[49.9%]);3444 例死亡[16.3%]源于心血管原因。在没有既往心血管疾病、糖尿病或高血压的 66 岁以下女性中,心血管死亡很少见。在 66 岁及以上的女性中,10 年内乳腺癌死亡和心血管死亡的风险分别为 11.9%(95%CI,11.6%-12.3%)和 7.6%(95%CI,7.3%-7.9%)。在有既往心血管疾病的患者中,前 5 年内乳腺癌和心血管疾病死亡风险相当,之后心血管疾病死亡风险更高(10 年累积发病率,乳腺癌为 14.6%[95%CI,13.7%-15.4%],心血管疾病为 16.9%[95%CI,16.0%-17.8%])。对于 66 岁及以上、乳腺癌诊断后存活 5 年或以上的女性,心血管疾病在诊断后 10 年成为导致死亡的主要原因,此时每种疾病的累积发生率均为 5%。

结论和相关性

心血管死亡是老年早期乳腺癌女性的一个重要竞争风险。这一发现要求在乳腺癌诊断后充分关注心血管预防治疗。

相似文献

1
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.基于人群的早期乳腺癌患者心血管死亡率研究。
JAMA Cardiol. 2017 Jan 1;2(1):88-93. doi: 10.1001/jamacardio.2016.3841.
2
Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.早期乳腺癌与后续化疗与心房颤动风险的关联。
JAMA Netw Open. 2019 Sep 4;2(9):e1911838. doi: 10.1001/jamanetworkopen.2019.11838.
3
All-Cause and Cancer-Specific Death of Older Adults Following Surgery for Cancer.老年癌症患者手术后的全因和癌症特异性死亡。
JAMA Surg. 2021 Jul 1;156(7):e211425. doi: 10.1001/jamasurg.2021.1425. Epub 2021 Jul 14.
4
Mammography use, breast cancer stage at diagnosis, and survival among older women.老年女性的乳房X光检查使用情况、诊断时的乳腺癌分期及生存率
J Am Geriatr Soc. 2000 Oct;48(10):1226-33. doi: 10.1111/j.1532-5415.2000.tb02595.x.
5
Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis.糖尿病患者的特定原因死亡风险:竞争风险分析。
Diabetes Care. 2016 Nov;39(11):1987-1995. doi: 10.2337/dc16-0614. Epub 2016 Aug 4.
6
Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: An Australian population-based study.2006 年至 2015 年澳大利亚人群癌症患者的心血管疾病和其他竞争死亡原因:一项基于人群的研究。
Cancer. 2019 Feb 1;125(3):442-452. doi: 10.1002/cncr.31806. Epub 2018 Oct 12.
7
All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.CLUE II 中长期社区队列中乳腺癌幸存者的全因和心血管疾病死亡率。
J Natl Cancer Inst. 2021 Feb 1;113(2):137-145. doi: 10.1093/jnci/djaa096.
8
Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study.早期乳腺癌后主要不良心血管事件的多变量预测模型的开发和验证:基于人群的队列研究。
Eur Heart J. 2019 Dec 21;40(48):3913-3920. doi: 10.1093/eurheartj/ehz460.
9
Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.乳腺导管原位癌女性中乳腺癌、心血管疾病及全因死亡率的种族差异。
Breast Cancer Res Treat. 2014 Nov;148(2):407-13. doi: 10.1007/s10549-014-3168-3. Epub 2014 Oct 18.
10
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.长期暴露于交通相关空气污染对荷兰呼吸道和心血管疾病死亡率的影响:荷兰长期队列空气污染研究(NLCS-AIR研究)
Res Rep Health Eff Inst. 2009 Mar(139):5-71; discussion 73-89.

引用本文的文献

1
Machine learning modeling of cancer treatment-related cardiac events in breast cancer: utilizing dosiomics and radiomics.乳腺癌中癌症治疗相关心脏事件的机器学习建模:利用剂量组学和影像组学
Front Oncol. 2025 Aug 21;15:1557382. doi: 10.3389/fonc.2025.1557382. eCollection 2025.
2
The risk of heart-specific death in breast cancer patients.乳腺癌患者心脏特异性死亡的风险。
Sci Rep. 2025 Aug 2;15(1):28228. doi: 10.1038/s41598-025-12648-6.
3
Long-term cardiovascular consequences of cancer therapy-related cardiac dysfunction: insights from ventricular-arterial coupling and myocardial work.
癌症治疗相关心脏功能障碍的长期心血管后果:来自心室-动脉耦合和心肌做功的见解
Eur Heart J Imaging Methods Pract. 2025 Jun 3;3(1):qyaf072. doi: 10.1093/ehjimp/qyaf072. eCollection 2025 Jan.
4
Evaluating the Necessity and Impact of Cardiac Imaging on Breast Cancer Care in Northwestern Ontario.评估安大略省西北部心脏成像在乳腺癌护理中的必要性及影响。
Cancers (Basel). 2025 Jun 8;17(12):1909. doi: 10.3390/cancers17121909.
5
Comparative Efficacy of Different Exercise Therapies for Cardiorespiratory Fitness in Breast Cancer Survivors: A Systematic Review and Bayesian Network Meta-analysis.不同运动疗法对乳腺癌幸存者心肺适能的比较疗效:一项系统评价和贝叶斯网络Meta分析
Sports Med Open. 2025 Jun 8;11(1):67. doi: 10.1186/s40798-025-00872-3.
6
Cardiovascular toxicity of breast cancer treatments: from understanding to enhancing survivorship care.乳腺癌治疗的心血管毒性:从认识到加强生存护理
ESMO Open. 2025 Jun 2;10(6):105128. doi: 10.1016/j.esmoop.2025.105128.
7
Transient increase in mitochondrial respiration in blood cells from breast cancer patients following chemo- and radiotherapy.化疗和放疗后乳腺癌患者血细胞中线粒体呼吸的短暂增加。
Clin Exp Med. 2025 May 8;25(1):142. doi: 10.1007/s10238-025-01665-4.
8
The association between life's crucial 9 and all-cause, cancer-specific and cardiovascular mortality in US cancer survivors: a cohort study of NHANES.美国癌症幸存者中生命关键9因素与全因死亡率、癌症特异性死亡率和心血管死亡率之间的关联:一项基于美国国家健康与营养检查调查(NHANES)的队列研究
BMC Cancer. 2025 Apr 30;25(1):805. doi: 10.1186/s12885-025-14229-2.
9
Extended adjuvant endocrine therapy in early breast cancer: finding the individual balance.早期乳腺癌的延长辅助内分泌治疗:寻求个体化平衡
ESMO Open. 2025 May;10(5):105057. doi: 10.1016/j.esmoop.2025.105057. Epub 2025 Apr 24.
10
The crosstalk of breast cancer and ischemic heart disease.乳腺癌与缺血性心脏病的相互影响
Cell Death Discov. 2025 Apr 18;11(1):185. doi: 10.1038/s41420-025-02428-6.